Showing results (41-50 of 51) with videos related to

Sort By:
Pageof 6
Arthritis and Rheumatism|October 19, 1999
Modulation of peripheral blood mononuclear cell activation status during Salmonella-triggered reactive arthritisJ Kirveskari, Q He, T Holmström, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 1991
Treatment of osteosarcoma of the extremities with the T-10 protocol, with emphasis on the effects of preoperative chemotherapy with single-agent high-dose methotrexate: a Scandinavian Sarcoma Group studyG Saeter, T A Alvegård, I Elomaa, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|April 1, 1990
Ten years' experience in patients with osteogenic sarcoma in FinlandI Elomaa, M A Siimes, C Blomqvist, et al.
Neuroreport|November 4, 1996
Lamin and beta-tubulin fragmentation precede chromatin degradation in glutamate-induced neuronal apoptosisM Ankarcrona, B Zhivotovsky, T Holmström, et al.
Molecular Membrane Biology|July 27, 1999
The lamprey (Lampetra fluviatilis) erythrocyte; morphology, ultrastructure, major plasma membrane proteins and phospholipids, and cytoskeletal organizationH Hägerstrand, M Danieluk, M Bobrowska-Hägerstrand, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|January 1, 1988
Clodronate for osteolytic metastases due to breast cancerI Elomaa, C Blomqvist, L Porkka, et al.
Scandinavian Journal of Plastic and Reconstructive Surgery and Hand Surgery|April 20, 1999
Desmoplastic fibroma of the calcaneus treated with a microvascular bone graft. Case reportT K Raatikainen, O I Kaarela, T Holmström, et al.
Lancet (London, England)|January 22, 1983
Long-term controlled trial with diphosphonate in patients with osteolytic bone metastasesI Elomaa, C Blomqvist, P Gröhn, et al.
Acta Medica Scandinavica|January 1, 1983
Long-term 1,25-dihydroxycholecalciferol treatment in renal failureL Hortling, F Fyhrquist, M V Bonsdorff, et al.
European Journal of Cancer (Oxford, England : 1990)|May 20, 2003
Scandinavian Sarcoma Group Osteosarcoma Study SSG VIII: prognostic factors for outcome and the role of replacement salvage chemotherapy for poor histological respondersS Smeland, C Müller, T A Alvegard, et al.
Pageof 6